SEC Form 4 · accession 0001140361-17-031347
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Sulpizio
Director
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Aug 9, 2017 | M | 24,390 | $33.70 | A | 28,819 | D | |
| ResMed Common StockF1 | Aug 9, 2017 | S | 24,390 | $73.85 | D | 4,429 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | Aug 9, 2017 | M | 24,390 | A | Nov 11, 2013 | Nov 11, 2017 | ResMed Common Stock | 24,390 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $73.53 to $74.20. The price reported above reflects the weighted average sale price.
- F2Represents date options first became exercisable.